Showing results (511-520 of 1,319) with videos related to
Sort By:
Pageof 132
Aging Cell|June 13, 2013
The significance of peroxisome function in chronological aging of Saccharomyces cerevisiaeSophie D Lefevre, Carlo W van Roermund, Ronald J A Wanders, et al.Annales De Medecine Interne|September 10, 2002
[Sjogren-Larsson syndrome: two cases with delayed diagnosis]Laurent Misery, Jean-Christophe Antoine, Renaud Touraine, et al.Journal of Gastroenterology|May 3, 2014
The human gastrointestinal tract-specific transcriptome and proteome as defined by RNA sequencing and antibody-based profilingGabriela Gremel, Alkwin Wanders, Jonathan Cedernaes, et al.Evolution; International Journal of Organic Evolution|January 10, 2023
Polygamy and purifying selection in birdsKees Wanders, Guangji Chen, Shaohong Feng, et al.Histochemistry|November 1, 1992
Does ex vivo labelling of proliferating cells in colonic and vaginal mucosa reflect the S-phase fraction in vivo?S L Wanders, J ten Kate, E van der Linden, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Phase I and pharmacokinetic study of E7070, a chloroindolyl-sulfonamide anticancer agent, administered on a weekly schedule to patients with solid tumorsChristian Dittrich, Herlinde Dumez, Hilary Calvert, et al.Journal of Inherited Metabolic Disease|July 17, 1999
Disorders of mitochondrial fatty acyl-CoA beta-oxidationR J Wanders, P Vreken, M E den Boer, et al.Biochimica Et Biophysica Acta|January 22, 2008
Cholesterol-deprivation increases mono-unsaturated very long-chain fatty acids in skin fibroblasts from patients with X-linked adrenoleukodystrophyM Engelen, R Ofman, P A W Mooijer, et al.British Journal of Cancer|February 1, 1996
Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials GroupS Kaplan, A R Hanauske, N Pavlidis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Topotecan in colorectal cancer: a phase II study of the EORTC early clinical trials groupG J Creemers, J Wanders, T Gamucci, et al.Pageof 132